Cadila Pharmaceuticals Ltd.

Amongst largest manufacturing groups in India with world class manufacturing infrastructure conforming to stringent international standards and GMP guidelines: WHO-GMP, US-FDA, UK‑MHRA, Australian-TGA (PIC Scheme), South African-MCC, ANVISA, Brazil, ISO 9002.

Large production capacities for sterile & non-sterile dosage forms (special units for ß-lactam range, insulins & rifampicin). International operations across 45 countries across 5 continents.

CONTRACT RESEARCH SERVICES [CRO]
Product Formulation Development, Bioequivalence, Clinical Research,

LICENSING & SUPPLY [EU CTD/ANDA]
Pharmaceuticals, Biogenerics, OTC & Herbal, Diagnostics

MARKETING & DISTRIBUTION:
India & 45+ operational markets

Activity:

- Clinical Trials
- Contract Manufacturing
- Contract Research
- Licensing & Business Development
- Manufacturing
- Market Research & Marketing
- Regulatory Affairs & Legal Services
- Research & Development
- Sales & Distribution
- Other Industry Services

Product / Technology type(s) covered:

- API / chemicals
- Bio
- Cosmoceuticals
- Curative
- Devices
- Diagnostics
- Generics
- FP (finished products)
- NCE (new chemical entities)
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics
- Phyto
- Nutritionals / Vitamins
- Prescription drugs (Rx)
- Preventive
- Technology

Therapeutic targets:

- Allergy
- Arthritis / Rheumato
- Asthma
- Cardiovascular
- Central nervous system
- Cough / Cold
- Diabetes
- Gastrointestinal
- Infectious Diseases
- Men's Health
- Mental Health
- Neurology
- Oncology
- Ophthalmology
- Orthopedics
- Pain
- Reproductive Health
- Stroke
- Surgery
- Tonics
- Urology

Markets Covered

a. HeadQuarter: India

b. Continent(s) active: Africa , Asia , Australia/New-Zealand , Europe , Far East , Near/Middle East , North America , Central/South America

c. Countries active: Over 45 countries

Corporate data:

Number of Employees: 3600

Turnover:

Amount:	Year:	Currency:
150000000	2002	US Dollar

Year founded: 1951

Partners / Alliances: Partnership proposals invited.